Cumberland Pharmaceuticals is Drug Delivery in United States that focus on Cumberland Pharmaceuticals Inc business. Founded in 1999. They cover business area such as Cumberland Pharmaceuticals Inc, development, commercialization, brand prescription product, acute care, gastroenterology, medical need, its product brand, Acetadote, Caldolor, Kristalose, Omeclamox- Pak, Vaprisol, Ethyol.
1999
( 25 years old in 2024 )
Cumberland Pharmaceuticals Inc
-
2525 West End Avenue
Suite 950
Nashville, TN 37203
United States
Private
Cumberland Pharmaceuticals Incdevelopmentcommercializationbrand prescription productacute caregastroenterologymedical needits product brandAcetadoteCaldolorKristaloseOmeclamox- PakVaprisolEthyol
* We use standard office opening hours in near Cumberland Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cumberland Pharmaceuticals is Drug Delivery business from United States that founded in 1999 (25 years old in 2024), Cumberland Pharmaceuticals business is focusing on Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals headquarter office and corporate office address is located in 2525 West End Avenue Suite 950 Nashville, TN 37203 United States.
Cumberland Pharmaceuticals was founded in United States.
In 2024, Cumberland Pharmaceuticals is currently focus on Cumberland Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Cumberland Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cumberland Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
